Biopharma Giant Gilead Sciences Secures 50,000 Sq Ft at One Triton Square as London's Knowledge Quarter Heats Up

Leading biopharma firm Gilead Sciences joins British Land and RLAM's One Triton Square at Regent’s Place. The building is now 77% let or under offer.

By: AXL Media

Published: Mar 12, 2026, 6:04 AM EDT

Source: Information for this report was sourced from British Land.

A Strategic Anchor for Regent’s Place Gilead Sciences, a global leader in virology and oncology, has committed to 50,000 sq ft of workspace within the One Triton Square development. This move places the biopharmaceutical firm at the heart of the "Knowledge Quarter," a dense cluster of academic, cultural, and scientific institutions. For Gilead, the relocation is an opportunity to scale its operations within a vibrant ecosystem designed for next-generation technologies. For British Land and RLAM, the lease validates their strategy of upgrading prime assets to meet the exacting technical standards required by modern life science occupiers.

Strong Leasing Momentum Post-Completion One Triton Square reached practical completion in October 2025 and has since experienced rapid take-up. According to British Land’s Q3 Trading Update, the building has recently seen five completed deals totaling 71,000 sq ft. With 77% of the building now let or under offer by Estimated Rental Value (ERV), the joint venture is well on its way to full occupancy. Kelly Cleveland, Head of Real Estate at British Land, noted that the success of the building reinforces the firm's conviction in taking strategic surrender premiums and securing high-quality lettings that unlock superior rental yields.

The Role of the 50/50 Joint Venture The development is a key pillar of the 50/50 joint venture established between British Land and Royal London Asset Management in March 2024. For RLAM, One Triton Square represents a marquee investment that complements its growing life science portfolio across the "Golden Triangle" of Oxford, Cambridge, and London. Mark Evans, Head of Property at RLAM, emphasized that the leasing success stands to deliver strong investment returns, proving the efficacy of their philosophy: deploying capital at scale into prime, well-connected buildings in core markets.

Life Sciences: The Engine of Central London Offices The influx of companies like Gilead Sciences into Regent’s Place highlights a broader trend in the London property market: the resilience of the science and tech sector amidst a wider office market transformation. While traditional corporate demand remains selective, biopharma and tech firms are actively seeking "plug-and-play" environments that foster collaboration and innovation. One Triton Square’s high connectivity and proximity to world-class research insti...